Skip to main content

Actinium Pharmaceuticals, Inc. (ATNM)

7.82 -0.18 (-2.25%)
Oct 27, 2021 12:25 PM EDT - Market open

Company Description

Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies.

Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19 CAR T-cell therapy with memorial sloan kettering cancer center.

The company is also developing a multi-disease, multi-target pipeline of clinical-stage antibody radiation-conjugates targeting the antigens CD45 and CD33 for targeted conditioning and as a therapeutic either in combination with other therapeutic modalities or as a single agent for patients with a range of hematologic malignancies, including acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma.

Actinium Pharmaceuticals, Inc. has research collaboration with Astellas Pharma, Inc. to develop targeted radiotherapies using its Antibody Warhead Enabling technology platforms.

The company was founded in 2000 and is based in New York, New York.

Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals Logo
CountryUnited States
SectorHealth Care
CEOSandesh Seth

Contact Details

275 Madison Ave Fl 7
New York, New York 10016-1101
United States
Phone646 677 3870

Stock Details

Ticker SymbolATNM
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001388320
CUSIP Number00507W107
ISIN NumberUS00507W2061
Employer ID74-2963609

Key Executives

Sandesh C. Seth M.B.A., M.S., MBAChairman and Chief Executive Officer
Steven O'Loughlin BSChief Financial Officer and Corporate Secretary
Dr. Paul Diamond Esq., Ph.D.Vice President of Patent and Legal Counsel
Dr. David GouldSenior Vice President of Corporate Development and Corporate Affairs
Dr. Bernie CunninghamExecutive Director of Clinical Supply Chain and Logistics and CMC Project Management
Dr. Qing LiangVice President and Head of Radiation Sciences
Dr. Robert N. Daly M.S., Ph.D.Vice President and Head of Clinical Operations
Dr. Mamata GokhaleVice President and Global Head of Regulatory Affairs
Dr. Avinash Desai M.D.Chief Medical Officer
Dr. Arun Swaminathan Ph.D.Chief Business and Commercial Officer